Huahai Pharmaceutical announced on the evening of October 17. Recently, the company's brief application for a new drug for englizin metformin tablets declared to the US FDA has been temporarily approved. Empagliflozin metformin tablets are mainly used to treat type II diabetes.

Zhitongcaijing · 10/17 07:41
Huahai Pharmaceutical announced on the evening of October 17. Recently, the company's brief application for a new drug for englizin metformin tablets declared to the US FDA has been temporarily approved. Empagliflozin metformin tablets are mainly used to treat type II diabetes.